Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cardiovascular Diabetology Année : 2023

Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records

Fichier principal
Vignette du fichier
BPH_CardiovascDiabetol_2023_Mohammedi.pdf (916.55 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04461501 , version 1 (16-02-2024)

Licence

Paternité

Identifiants

Citer

Kamel Mohammedi, Audrey Cordon, Vincent Rigalleau, Ninon Foussard, Celine Bairras-Martin, et al.. Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records. Cardiovascular Diabetology, 2023, 22 (1), pp.329. ⟨10.1186/s12933-023-02069-y⟩. ⟨hal-04461501⟩

Collections

CNRS U1219 U1034
14 Consultations
4 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More